Free Trial
NASDAQ:VERO

Venus Concept (VERO) Stock Price, News & Analysis

Venus Concept logo
$0.43
+0.02 (+4.88%)
(As of 11/1/2024 ET)

About Venus Concept Stock (NASDAQ:VERO)

Key Stats

Today's Range
$0.37
$0.44
50-Day Range
$0.34
$0.86
52-Week Range
$0.33
$2.27
Volume
605,768 shs
Average Volume
1.15 million shs
Market Capitalization
$3.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Receive VERO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Venus Concept and its competitors with MarketBeat's FREE daily newsletter.

VERO Stock News Headlines

Venus Concept files $30.37M mixed securities shelf
Elon knows the truth, which is why they want him silenced
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
See More Headlines

VERO Stock Analysis - Frequently Asked Questions

Venus Concept's stock was trading at $1.18 on January 1st, 2024. Since then, VERO shares have decreased by 63.6% and is now trading at $0.43.
View the best growth stocks for 2024 here
.

Venus Concept Inc. (NASDAQ:VERO) released its earnings results on Tuesday, August, 13th. The company reported ($1.39) earnings per share for the quarter. The firm had revenue of $16.58 million for the quarter.

Shares of Venus Concept reverse split before market open on Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of VERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Venus Concept investors own include Tesla (TSLA), Agenus (AGEN), Cisco Systems (CSCO), Taiwan Semiconductor Manufacturing (TSM), Intel (INTC), Pfizer (PFE) and Palantir Technologies (PLTR).

Company Calendar

Last Earnings
8/13/2024
Today
11/02/2024
Next Earnings (Confirmed)
11/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:VERO
Fax
N/A
Employees
410
Year Founded
N/A

Profitability

Net Income
$-37,250,000.00
Pretax Margin
-71.73%

Debt

Sales & Book Value

Annual Sales
$76.35 million
Book Value
($2.43) per share

Miscellaneous

Free Float
3,049,000
Market Cap
$3.12 million
Optionable
Not Optionable
Beta
0.51
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (NASDAQ:VERO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners